Ruhr University Bochum News
Latest articles and news about Ruhr University Bochum on AXL Media.
Latest Articles
- Molecular Hijacking Discovered as Pseudomonas Syringae Pathogens Disable Plant Defenses via RNA Sequestration
Published: Apr 29, 2026
Section: Research
A research team at Ruhr-University Bochum has identified how specific bacteria manipulate plant cells by inducing droplet-like structures that trap vital genetic instructions. By t...
- Ruhr University Researchers Develop Ruthenium Agent to Kill Cancer in Oxygen-Depleted Tumors
Published: Apr 7, 2026
Section: Medical News
A research group at Ruhr University Bochum has achieved a breakthrough in photodynamic therapy (PDT) by developing a ruthenium-based agent that remains lethal in hypoxic, oxygen-de...
- Repurposed Hepatitis C Drug Bemnifosbuvir Shows Potential to Halt Global Hepatitis E Mortality
Published: Apr 6, 2026
Section: Medical News
An international research coalition has identified bemnifosbuvir as a potent inhibitor of hepatitis E replication, offering a potential breakthrough for a virus that kills 70,000 p...
- Molecular Brake Discovered in Diarrheal Pathogens Prevents Premature Activation of Virulence Outside the Human Host
Published: Apr 3, 2026
Section: Health Technology
Researchers at Ruhr University Bochum and the University of Münster have identified the Fis protein as a critical regulator that suppresses the lethal capabilities of Yersinia pseu...
- Light-Activated Copper Complex Kills Treatment-Resistant Cancer Cells One Hundred Times More Effectively Than Traditional Chemotherapy
Published: Mar 26, 2026
Section: Research
Researchers at Ruhr University Bochum have developed a nanoparticle-based copper agent that utilizes a recently discovered cell death mechanism called cuproptosis. By using light t...
- International Researchers Identify Hepatitis C Clinical Trial Drug as Potential Breakthrough Treatment for Hepatitis E Virus
Published: Mar 23, 2026
Section: Health
A collaborative study between German and Chinese researchers has identified bemnifosbuvir, an antiviral currently in clinical trials for Hepatitis C, as a potent inhibitor of Hepat...
- Groundbreaking Discovery Of CD99L2 Gene Variants Solves Genetic Mystery Of X Linked Spastic Ataxia
Published: Mar 17, 2026
Section: Science & Tech
A collaborative study between researchers in Bochum and Tübingen has identified the CD99L2 gene as a primary driver of rare movement disorders. By analyzing a cohort of nearly 3,00...
- Scientific Breakthrough Identifies CD99L2 Gene as Primary Cause of Rare X-Linked Spastic Ataxia
Published: Mar 17, 2026
Section: Science & Tech
A joint research team from Bochum and Tübingen has pinpointed disease causing variants of the CD99L2 gene in a massive cohort of 2,811 patients. The study, published in Nature Comm...
- Ruhr University Study Reveals Cortisol Disrupts Grid Cell Stability, Impairing Brain's Internal GPS and Navigation Accuracy
Published: Mar 14, 2026
Section: Health
Researchers in Germany have demonstrated that the stress hormone cortisol significantly destabilizes grid cells in the entorhinal cortex, leading to severe orientation errors. The...